IART

IART

USD

Integra LifeSciences Holdings Corporation Common Stock

$11.300-0.090 (-0.790%)

Precio en Tiempo Real

Healthcare
Dispositivos médicos
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$11.390

Máximo

$11.600

Mínimo

$11.220

Volumen

0.19M

Fundamentos de la Empresa

Capitalización de Mercado

880.2M

Industria

Dispositivos médicos

País

United States

Estadísticas de Negociación

Volumen Promedio

1.22M

Bolsa

NMS

Moneda

USD

Rango de 52 Semanas

Mínimo $11.05Actual $11.300Máximo $27.13

Noticias Relacionadas

Analyst Upgrades

Truist Securities Reiterates Hold on Integra Lifesciences, Lowers Price Target to $13

Truist Securities analyst Ravi Misra reiterates Integra Lifesciences with a Hold and lowers the price target from $15 to $13.

Ver más
Truist Securities Reiterates Hold on Integra Lifesciences, Lowers Price Target to $13
Analyst Upgrades

Citigroup Maintains Sell on Integra Lifesciences, Lowers Price Target to $11

Citigroup analyst Joanne Wuensch maintains Integra Lifesciences with a Sell and lowers the price target from $12 to $11.

Ver más
Citigroup Maintains Sell on Integra Lifesciences, Lowers Price Target to $11
Analyst Upgrades

JP Morgan Maintains Underweight on Integra Lifesciences, Raises Price Target to $13

JP Morgan analyst Robbie Marcus maintains Integra Lifesciences with a Underweight and raises the price target from $12 to $13.

Ver más
JP Morgan Maintains Underweight on Integra Lifesciences, Raises Price Target to $13
GlobeNewswire

Integra LifeSciences Reports Third Quarter 2025 Financial Results

PRINCETON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today reported financial results for the third quarter ending

Ver más
Integra LifeSciences Reports Third Quarter 2025 Financial Results

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.